Bank Of Montreal

Direxion Daily Semicondct Bull 3X ETF

ProShares Ultra Bloomberg Natural Gas

Direxion Daily S&P Biotech Bull 3X ETF

Direxion Daily Small Cap Bull 3X ETF

Direxion Daily Financial Bull 3X ETF

VS TR -1x Short VIX Futures ETF

Direxion Daily Technology Bull 3X ETF

United States Natural Gas

ProShares UltraPro Dow30

VS TR 2x Long VIX Futures ETF

ProShares Ultra VIX Short-Term Futures

Direxion Daily Semicondct Bear 3X ETF

ProShares UltraShort Bloomberg Natrl Gas

Direxion Daily S&P Biotech Bear 3X ETF

Direxion Daily Small Cap Bear 3X ETF

Direxion Financial Bear 3X Shar

MicroSectors Gold Miners 3X Leveraged ETN

Direxion Technology Bear 3X Shares

ProShares Ultra Silver

Genworth Financial Inc Common Stock

Granite Point Mortgage Trust Inc. Common Stock

RE/MAX Holdings Inc. Class A Common Stock

JinkoSolar Holding Company Limited American Depositary Shares (each representing 4 Common Shares)

WESCO International Inc. Common Stock

TKO Group Holdings Inc. Class A Common Stock

JELD-WEN Holding Inc. Common Stock

Archer Aviation Inc. Class A Common Stock

Affiliated Managers Group Inc. Common Stock

Bath & Body Works Inc.

Spotify Technology S.A. Ordinary Shares

Hecla Mining Company Common Stock

UBS Group AG Registered Ordinary Shares

Allstate Corporation (The) Common Stock

Telefonica SA Common Stock

Halliburton Company Common Stock

First Majestic Silver Corp. Ordinary Shares (Canada)

Pan American Silver Corp. Common Stock

ServiceNow Inc. Common Stock

Endeavour Silver Corporation Ordinary Shares (Canada)

Click here to get full coverage on Abacus Global Management, Inc. (ABL) Shares Tumble Following Second Morpheus Report – Hagens Berman - GlobeNewswire

Abacus Global Management, Inc. (ABL) Shares Tumble Following Second Morpheus Report – Hagens Berman  GlobeNewswire

Abacus Global Management, Inc. (ABL) Shares Tumble Following Second Morpheus Report – Hagens Berman - GlobeNewswire

Click here to get full coverage on Abacus Life (NASDAQ:ABL) Stock Price Down 7.1% - What's Next? - MarketBeat

Abacus Life (NASDAQ:ABL) Stock Price Down 7.1% - What's Next?  MarketBeat

Abacus Life (NASDAQ:ABL) Stock Price Down 7.1% - What's Next? - MarketBeat

Click here to get full coverage on Innosea rebrands as OWC, strengthening ABL Group’s renewables offering - Offshore Energy

Innosea rebrands as OWC, strengthening ABL Group’s renewables offering  Offshore Energy

Innosea rebrands as OWC, strengthening ABL Group’s renewables offering - Offshore Energy

Click here to get full coverage on Securities Fraud Investigation Into Abacus Global Management, Inc. (ABL) Continues – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz - TradingView

Securities Fraud Investigation Into Abacus Global Management, Inc. (ABL) Continues – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz  TradingView

Securities Fraud Investigation Into Abacus Global Management, Inc. (ABL) Continues – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz - TradingView

Click here to get full coverage on ABL Bio Announces Grabody-B Brain Delivery Platform License Agreement with GSK to Develop Novel Medicines for Neurodegenerative Diseases - PR Newswire

ABL Bio Announces Grabody-B Brain Delivery Platform License Agreement with GSK to Develop Novel Medicines for Neurodegenerative Diseases  PR Newswire

ABL Bio Announces Grabody-B Brain Delivery Platform License Agreement with GSK to Develop Novel Medicines for Neurodegenerative Diseases - PR Newswire

Click here to get full coverage on Bronstein, Gewirtz & Grossman, LLC Is Investigating Abacus Global Management, Inc. (ABL) And Encourages Investors to Connect - ACCESS Newswire

Bronstein, Gewirtz & Grossman, LLC Is Investigating Abacus Global Management, Inc. (ABL) And Encourages Investors to Connect  ACCESS Newswire

Bronstein, Gewirtz & Grossman, LLC Is Investigating Abacus Global Management, Inc. (ABL) And Encourages Investors to Connect - ACCESS Newswire

Click here to get full coverage on ABL, a style commerce platform operated by ABL Corporation (CEO Kang Seok-hoon), announced on the 18.. - 매일경제

ABL, a style commerce platform operated by ABL Corporation (CEO Kang Seok-hoon), announced on the 18..  매일경제

ABL, a style commerce platform operated by ABL Corporation (CEO Kang Seok-hoon), announced on the 18.. - 매일경제

Click here to get full coverage on GSK pens $2.5B pact for ABL Bio's tech to help antibodies bypass blood-brain barrier - Fierce Biotech

GSK pens $2.5B pact for ABL Bio's tech to help antibodies bypass blood-brain barrier  Fierce Biotech

GSK pens $2.5B pact for ABL Bio's tech to help antibodies bypass blood-brain barrier - Fierce Biotech

Click here to get full coverage on ABL Space renamed Long Wall as it shifts focus to defense market - SpaceNews

ABL Space renamed Long Wall as it shifts focus to defense market  SpaceNews

ABL Space renamed Long Wall as it shifts focus to defense market - SpaceNews

Click here to get full coverage on Inside the rise and fall of the ABL pro women's hoops league - ESPN

Inside the rise and fall of the ABL pro women's hoops league  ESPN

Inside the rise and fall of the ABL pro women's hoops league - ESPN

Click here to get full coverage on GSK Dives Deeper Into Neuro With $2.5B+ ABL Bio Pact - BioSpace

GSK Dives Deeper Into Neuro With $2.5B+ ABL Bio Pact  BioSpace

GSK Dives Deeper Into Neuro With $2.5B+ ABL Bio Pact - BioSpace

Click here to get full coverage on ABL Investors Have Opportunity to Join Abacus Global Management, Inc. Fraud Investigation with the Schall Law Firm - Business Wire

ABL Investors Have Opportunity to Join Abacus Global Management, Inc. Fraud Investigation with the Schall Law Firm  Business Wire

ABL Investors Have Opportunity to Join Abacus Global Management, Inc. Fraud Investigation with the Schall Law Firm - Business Wire

Click here to get full coverage on BCR-ABL: The Molecular Mastermind behind Chronic Myeloid Leukemia - ScienceDirect.com

BCR-ABL: The Molecular Mastermind behind Chronic Myeloid Leukemia  ScienceDirect.com

BCR-ABL: The Molecular Mastermind behind Chronic Myeloid Leukemia - ScienceDirect.com

Click here to get full coverage on GSK Inks Pact Worth up to $2.5B with ABL Bio on Neuro Drugs - Inside Precision Medicine

GSK Inks Pact Worth up to $2.5B with ABL Bio on Neuro Drugs  Inside Precision Medicine

GSK Inks Pact Worth up to $2.5B with ABL Bio on Neuro Drugs - Inside Precision Medicine

Click here to get full coverage on ABL Replaces CEO To Build A Missile Defense System - payloadspace.com

ABL Replaces CEO To Build A Missile Defense System  payloadspace.com

ABL Replaces CEO To Build A Missile Defense System - payloadspace.com

Click here to get full coverage on BetterLesson Acquires Abl - PR Newswire

BetterLesson Acquires Abl - PR Newswire

Click here to get full coverage on ABL DOWN 15%: Block & Leviton Investigating Abacus Global - GlobeNewswire

ABL DOWN 15%: Block & Leviton Investigating Abacus Global  GlobeNewswire

ABL DOWN 15%: Block & Leviton Investigating Abacus Global - GlobeNewswire

Click here to get full coverage on ABL Space exits commercial launch market, shifts focus to missile defense - SpaceNews

ABL Space exits commercial launch market, shifts focus to missile defense  SpaceNews

ABL Space exits commercial launch market, shifts focus to missile defense - SpaceNews

Click here to get full coverage on ABL INVESTIGATION NOTICE: Robbins Geller Rudman & Dowd LLP - GlobeNewswire

ABL INVESTIGATION NOTICE: Robbins Geller Rudman & Dowd LLP  GlobeNewswire

ABL INVESTIGATION NOTICE: Robbins Geller Rudman & Dowd LLP - GlobeNewswire

Click here to get full coverage on GPX1 confers resistance to metabolic stress in BCR/ABL-T315I mutant chronic myeloid leukemia cells - Nature

GPX1 confers resistance to metabolic stress in BCR/ABL-T315I mutant chronic myeloid leukemia cells  Nature

GPX1 confers resistance to metabolic stress in BCR/ABL-T315I mutant chronic myeloid leukemia cells - Nature

Click here to get full coverage on Abacus Life (NASDAQ:ABL) Trading Up 4.3% - Here's What Happened - MarketBeat

Abacus Life (NASDAQ:ABL) Trading Up 4.3% - Here's What Happened  MarketBeat

Abacus Life (NASDAQ:ABL) Trading Up 4.3% - Here's What Happened - MarketBeat

Click here to get full coverage on Arbuthnot Commercial ABL backs FDS Group with £3m growth facility - Asset Finance Connect

Arbuthnot Commercial ABL backs FDS Group with £3m growth facility  Asset Finance Connect

Arbuthnot Commercial ABL backs FDS Group with £3m growth facility - Asset Finance Connect

Click here to get full coverage on GSK, ABL Bio Ink Up-to-$2.75B+ Neurodegenerative Collaboration - Genetic Engineering and Biotechnology News

GSK, ABL Bio Ink Up-to-$2.75B+ Neurodegenerative Collaboration  Genetic Engineering and Biotechnology News

GSK, ABL Bio Ink Up-to-$2.75B+ Neurodegenerative Collaboration - Genetic Engineering and Biotechnology News

Click here to get full coverage on ABL Pivots To Missile Defense - payloadspace.com

ABL Pivots To Missile Defense  payloadspace.com

ABL Pivots To Missile Defense - payloadspace.com

Click here to get full coverage on GSK strikes £2.1B deal for ABL's neurotherapeutics platform - FirstWord Pharma

GSK strikes £2.1B deal for ABL's neurotherapeutics platform  FirstWord Pharma

GSK strikes £2.1B deal for ABL's neurotherapeutics platform - FirstWord Pharma

Click here to get full coverage on Wilson Sonsini Advises ABL Bio on Worldwide Licensing Agreement with GSK - Wilson Sonsini

Wilson Sonsini Advises ABL Bio on Worldwide Licensing Agreement with GSK  Wilson Sonsini

Wilson Sonsini Advises ABL Bio on Worldwide Licensing Agreement with GSK - Wilson Sonsini

Click here to get full coverage on Third-Party Actuaries Confirm Abacus $449M Portfolio Value, Debunking Short Seller Claims - Stock Titan

Third-Party Actuaries Confirm Abacus $449M Portfolio Value, Debunking Short Seller Claims  Stock Titan

Third-Party Actuaries Confirm Abacus $449M Portfolio Value, Debunking Short Seller Claims - Stock Titan

Click here to get full coverage on TERN-701 Decreases BCR-ABL Levels, Generates Molecular Responses in R/R CML - OncLive

TERN-701 Decreases BCR-ABL Levels, Generates Molecular Responses in R/R CML  OncLive

TERN-701 Decreases BCR-ABL Levels, Generates Molecular Responses in R/R CML - OncLive

Click here to get full coverage on ABL Space Systems lays off staff - SpaceNews

ABL Space Systems lays off staff  SpaceNews

ABL Space Systems lays off staff - SpaceNews

Click here to get full coverage on CDK8/19 inhibition attenuates G1 arrest induced by BCR-ABL antagonists and accelerates death of chronic myelogenous leukemia cells - Nature

CDK8/19 inhibition attenuates G1 arrest induced by BCR-ABL antagonists and accelerates death of chronic myelogenous leukemia cells  Nature

CDK8/19 inhibition attenuates G1 arrest induced by BCR-ABL antagonists and accelerates death of chronic myelogenous leukemia cells - Nature

Click here to get full coverage on Abacus Life, Inc. (ABL) Reports Next Week: Wall Street Expects Earnings Growth - Yahoo Finance

Abacus Life, Inc. (ABL) Reports Next Week: Wall Street Expects Earnings Growth  Yahoo Finance

Abacus Life, Inc. (ABL) Reports Next Week: Wall Street Expects Earnings Growth - Yahoo Finance

Click here to get full coverage on Fire, fed by leaking engines, destroyed ABL Space Systems rocket - SpaceNews

Fire, fed by leaking engines, destroyed ABL Space Systems rocket  SpaceNews

Fire, fed by leaking engines, destroyed ABL Space Systems rocket - SpaceNews

Click here to get full coverage on ABL Bio Announces Clinical Collaboration to Evaluate ABL103 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Solid Tumors - PR Newswire

ABL Bio Announces Clinical Collaboration to Evaluate ABL103 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Solid Tumors  PR Newswire

ABL Bio Announces Clinical Collaboration to Evaluate ABL103 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Solid Tumors - PR Newswire

Click here to get full coverage on Abacus Life, Inc. (ABL) Soars 6.9%: Is Further Upside Left in the Stock? - Yahoo Finance

Abacus Life, Inc. (ABL) Soars 6.9%: Is Further Upside Left in the Stock?  Yahoo Finance

Abacus Life, Inc. (ABL) Soars 6.9%: Is Further Upside Left in the Stock? - Yahoo Finance

Click here to get full coverage on Is Abacus Global Management (ABL) A Small Cap Stock with Huge Upside Potential? - Yahoo Finance

Is Abacus Global Management (ABL) A Small Cap Stock with Huge Upside Potential?  Yahoo Finance

Is Abacus Global Management (ABL) A Small Cap Stock with Huge Upside Potential? - Yahoo Finance

Click here to get full coverage on After raising nearly half a billion dollars, ABL Space pivots from launch vehicles to missiles - TechCrunch

After raising nearly half a billion dollars, ABL Space pivots from launch vehicles to missiles  TechCrunch

After raising nearly half a billion dollars, ABL Space pivots from launch vehicles to missiles - TechCrunch

Click here to get full coverage on CD36 cell surface expression as a surrogate marker to identify ABL/JAK-class kinase fusions in pediatric BCP-ALL - Nature

CD36 cell surface expression as a surrogate marker to identify ABL/JAK-class kinase fusions in pediatric BCP-ALL  Nature

CD36 cell surface expression as a surrogate marker to identify ABL/JAK-class kinase fusions in pediatric BCP-ALL - Nature

Click here to get full coverage on Rocket Startup ABL Reduces its Workforce - payloadspace.com

Rocket Startup ABL Reduces its Workforce  payloadspace.com

Rocket Startup ABL Reduces its Workforce - payloadspace.com

Click here to get full coverage on ABL Aviation, Embraer Join Forces In $400M E-Jet E2 Financing Deal - Aviation Week Network

ABL Aviation, Embraer Join Forces In $400M E-Jet E2 Financing Deal  Aviation Week Network

ABL Aviation, Embraer Join Forces In $400M E-Jet E2 Financing Deal - Aviation Week Network

Click here to get full coverage on Abacus Life, Inc. (ABL) Surpasses Q4 Earnings and Revenue Estimates - Yahoo Finance

Abacus Life, Inc. (ABL) Surpasses Q4 Earnings and Revenue Estimates  Yahoo Finance

Abacus Life, Inc. (ABL) Surpasses Q4 Earnings and Revenue Estimates - Yahoo Finance

Click here to get full coverage on White Oak Commercial Finance Funds $125 Million ABL Facility for Energy Services Company - Business Wire

White Oak Commercial Finance Funds $125 Million ABL Facility for Energy Services Company  Business Wire

White Oak Commercial Finance Funds $125 Million ABL Facility for Energy Services Company - Business Wire

Click here to get full coverage on ABL to oversee installation for US-Canada connector - Renewable Energy News

ABL to oversee installation for US-Canada connector  Renewable Energy News

ABL to oversee installation for US-Canada connector - Renewable Energy News

Click here to get full coverage on As ABL Space departs launch, the 1-ton rocket wars have a clear winner - Ars Technica

As ABL Space departs launch, the 1-ton rocket wars have a clear winner  Ars Technica

As ABL Space departs launch, the 1-ton rocket wars have a clear winner - Ars Technica

Click here to get full coverage on Is Abacus Life, Inc. (ABL) The Oversold Financial Stock To Buy Right Now? - Yahoo Finance

Is Abacus Life, Inc. (ABL) The Oversold Financial Stock To Buy Right Now?  Yahoo Finance

Is Abacus Life, Inc. (ABL) The Oversold Financial Stock To Buy Right Now? - Yahoo Finance

Click here to get full coverage on Abacus Global Management Inc (ABL) Q1 2025 Earnings Report Preview: What To Expect - Yahoo Finance

Abacus Global Management Inc (ABL) Q1 2025 Earnings Report Preview: What To Expect  Yahoo Finance

Abacus Global Management Inc (ABL) Q1 2025 Earnings Report Preview: What To Expect - Yahoo Finance

Click here to get full coverage on ABL loses rocket after static-fire test - SpaceNews

ABL loses rocket after static-fire test  SpaceNews

ABL loses rocket after static-fire test - SpaceNews

Click here to get full coverage on Fierce Pharma Asia—Congress' US-China biotech report; NIH's database ban; GSK's ABL neuroscience deal - Fierce Pharma

Fierce Pharma Asia—Congress' US-China biotech report; NIH's database ban; GSK's ABL neuroscience deal  Fierce Pharma

Fierce Pharma Asia—Congress' US-China biotech report; NIH's database ban; GSK's ABL neuroscience deal - Fierce Pharma

Click here to get full coverage on Rocket startup ABL Space Systems ends orbital launch plans, pivots to missile defense - Space

Rocket startup ABL Space Systems ends orbital launch plans, pivots to missile defense  Space

Rocket startup ABL Space Systems ends orbital launch plans, pivots to missile defense - Space

Click here to get full coverage on TAB Bank Secures $4 million ABL and $2.5 million Equipment Loan for HydroEdge Solutions to Drive Expansion - GlobeNewswire

TAB Bank Secures $4 million ABL and $2.5 million Equipment Loan for HydroEdge Solutions to Drive Expansion  GlobeNewswire

TAB Bank Secures $4 million ABL and $2.5 million Equipment Loan for HydroEdge Solutions to Drive Expansion - GlobeNewswire

Click here to get full coverage on 41st IBCT Soldiers Patrol ABL in Kosovo [Image 4 of 6] - DVIDS

41st IBCT Soldiers Patrol ABL in Kosovo [Image 4 of 6]  DVIDS

41st IBCT Soldiers Patrol ABL in Kosovo [Image 4 of 6] - DVIDS

Click here to get full coverage on SUMOylation facilitates the stability of BCR-ABL to promote chronic myeloid leukemia progression | Oncogene - Nature

SUMOylation facilitates the stability of BCR-ABL to promote chronic myeloid leukemia progression | Oncogene  Nature

SUMOylation facilitates the stability of BCR-ABL to promote chronic myeloid leukemia progression | Oncogene - Nature

Click here to get full coverage on Trilateral Maritime Capabilities Test a Stepping-Stone Toward Future AUKUS Successes - U.S. Department of Defense (.gov)

Trilateral Maritime Capabilities Test a Stepping-Stone Toward Future AUKUS Successes  U.S. Department of Defense (.gov)

Trilateral Maritime Capabilities Test a Stepping-Stone Toward Future AUKUS Successes - U.S. Department of Defense (.gov)

Click here to get full coverage on ABL Space System's 2nd RS1 rocket destroyed during preflight testing - Space

ABL Space System's 2nd RS1 rocket destroyed during preflight testing  Space

ABL Space System's 2nd RS1 rocket destroyed during preflight testing - Space

Click here to get full coverage on ABL Space Systems’ RS1 rocket suffers ‘irrecoverable damage’ in fire at spaceport - news.satnews.com

ABL Space Systems’ RS1 rocket suffers ‘irrecoverable damage’ in fire at spaceport  news.satnews.com

Abacus Life Inc. (ABL)

Price Chart

Key Statistics

Technicals

About ABL

Latest News

Abacus Global Management, Inc. (ABL) Shares Tumble Following Second Morpheus Report – Hagens Berman - GlobeNewswire

Abacus Life (NASDAQ:ABL) Stock Price Down 7.1% - What's Next? - MarketBeat

Innosea rebrands as OWC, strengthening ABL Group’s renewables offering - Offshore Energy

Advanced Charts

Top Gainers

Top Losers